COLL
Collegium Pharmaceutical Inc
NASDAQ: COLL · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$33.76
+2.90% today
Updated 2026-04-29
Market cap
$1.09B
P/E ratio
19.51
P/S ratio
1.40x
EPS (TTM)
$1.73
Dividend yield
—
52W range
$27 – $51
Volume
0.6M
Collegium Pharmaceutical Inc (COLL) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $1.71M | $28.48M | $280.41M | $296.70M | $310.02M | $276.87M | $463.93M | $566.77M | $631.45M | $780.57M |
| Revenue growth (YoY) | — | — | — | — | +1564.3% | +884.7% | +5.8% | +4.5% | -10.7% | +67.6% | +22.2% | +11.4% | +23.6% |
| Cost of revenue | — | $0.00 | $171000.00 | $213000.00 | $2.60M | $165.68M | $193.66M | $130.18M | $126.25M | $254.44M | $240.60M | $254.10M | $317.31M |
| Gross profit | — | $0.00 | $-171000.00 | $1.50M | $25.88M | $114.74M | $103.04M | $179.84M | $150.62M | $209.49M | $326.17M | $377.34M | $463.26M |
| Gross margin | — | — | — | 87.6% | 90.9% | 40.9% | 34.7% | 58.0% | 54.4% | 45.2% | 57.5% | 59.8% | 59.3% |
| R&D | $14.16M | $14.96M | $7.97M | $14.95M | $8.57M | $8.66M | $10.34M | $9.77M | $9.45M | $3.98M | $0.00 | $0.00 | — |
| SG&A | $1.89M | $2.71M | $18.93M | $80.63M | $92.76M | $126.76M | $116.45M | $108.46M | $114.77M | $160.44M | $151.80M | $172.32M | $284.80M |
| Operating income | $-16.04M | $-17.66M | $-26.91M | $-94.08M | $-75.45M | $-20.68M | $-23.75M | $56.23M | $17.63M | $33.32M | $166.96M | $169.90M | $187.08M |
| Operating margin | — | — | — | -5498.7% | -264.9% | -7.4% | -8.0% | 18.1% | 6.4% | 7.2% | 29.5% | 26.9% | 24.0% |
| EBITDA | $-15.95M | $-17.48M | $-26.74M | $-93.43M | $-74.27M | $91.91M | $-6.33M | $118.01M | $86.56M | $173.31M | $308.33M | $341.70M | $401.00M |
| EBITDA margin | — | — | — | -5460.4% | -260.8% | 32.8% | -2.1% | 38.1% | 31.3% | 37.4% | 54.4% | 54.1% | 51.4% |
| EBIT | $-16.12M | $-17.66M | $-26.91M | $-94.08M | $-74.86M | $-19.00M | $-21.81M | $56.46M | $17.64M | $34.37M | $159.07M | $172.54M | $174.93M |
| Interest expense | $76000.00 | $252000.00 | $439000.00 | $94000.00 | $582000.00 | $20.13M | $909000.00 | $28.88M | $21.01M | $63.21M | $83.34M | $73.97M | $82.31M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-16.20M | $-17.92M | $-27.25M | $-94.18M | $-74.86M | $-39.13M | $-22.72M | $26.75M | $71.52M | $-25.00M | $48.16M | $69.19M | $62.87M |
| Net income growth (YoY) | — | -10.6% | -52.1% | -245.5% | +20.5% | +47.7% | +41.9% | +217.7% | +167.3% | -135.0% | +292.6% | +43.7% | -9.1% |
| Profit margin | — | — | — | -5504.1% | -262.9% | -14.0% | -7.7% | 8.6% | 25.8% | -5.4% | 8.5% | 11.0% | 8.1% |